Related Experiment Video
Updated: Jun 20, 2026

Direct Detection of the Acetate-forming Activity of the Enzyme Acetate Kinase
Published on: December 19, 2011
In silico characterization of the interaction of AKR1B1 with the deacetylase activation domain (DAD)
Francisco J Gómez-Zaldívar1,2, Luis Córdova-Bahena1,3, Angel J Ruiz-Moreno1
1School of Medicine, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
Abstract:
The aldo-keto reductase family 1 member B1 (AKR1B1) plays a key role in cancer progression by competing with histone deacetylase 3 to bind to the deacetylase activation domain (DAD) of the nuclear receptor corepressor SMRT. Previous studies showed that the L289A mutation in AKR1B1 disrupts its ability to form a dimer with DAD but further details of this interaction remain uncharacterized. This study aimed to model the DAD/AKR1B1 dimer by molecular docking and characterize the complex using molecular dynamics simulations. We identified a new model with increased structural stability for AKR1B1, reduced disruption of secondary structures of DAD, and lower ΔG than a previously reported one. In silico mutagenesis of AKR1B1 assessed the contributions from individual residues. We identified six hotspot residues that mediate the complex interface. Those residues are located in the α8 and H2 alpha helices of AKR1B1 and include the experimentally determined L289. These results propose new hypotheses regarding the interaction between DAD and AKR1B1, guiding future experimental approaches.
Insights
Aldo-keto reductase family 1 member B1 (AKR1B1) interacts with SMRT
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Aldo-keto reductase family 1 member B1 (AKR1B1) is implicated in cancer progression.
- AKR1B1 competes with histone deacetylase 3 for binding to the deacetylase activation domain (DAD) of SMRT.
- The L289A mutation in AKR1B1 affects its dimerization with DAD, but the interaction details are unclear.
Purpose of the Study:
- To model the DAD/AKR1B1 dimer using molecular docking.
- To characterize the DAD/AKR1B1 complex stability and interactions via molecular dynamics simulations.
- To identify key residues mediating the DAD/AKR1B1 interface through in silico mutagenesis.
Main Methods:
- Molecular docking to model the DAD/AKR1B1 dimer.
- Molecular dynamics simulations to analyze complex stability and structural dynamics.
- In silico mutagenesis to assess residue contributions to the interface.
Main Results:
- A novel, more stable DAD/AKR1B1 dimer model was identified.
- The new model showed reduced disruption of DAD secondary structures and a lower binding free energy (ΔG).
- Six hotspot residues, including L289, located in AKR1B1's α8 and H2 helices were identified as critical for the interface.
Conclusions:
- The study provides a refined model of the DAD/AKR1B1 interaction.
- Key residues mediating the complex interface were identified, offering insights into AKR1B1's role in cancer.
- These findings guide future experimental validation and therapeutic strategies targeting the DAD/AKR1B1 interaction.
Related Concept Videos
Enzyme Inhibition
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Ligand Binding and Linkage
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

